Author: Genvor Inc

Posted Date:

April 14, 2026

Genvor Announces Strategic Memorandum of Understanding with Canlab International™ to Advance Commercial Peptide Pipeline

Genvor Inc

April 14, 2026
Genvor, Inc. Presenting at NIBA’s 152nd Investment Conference in Fort Lauderdale, FL March 12, 2026

Genvor Inc

March 5, 2026
Genvor Announces Strategic Expansion into Health and Wellness Market, Leveraging Proprietary AI-Accelerated BioCypher Platform to Develop Consumer Peptide Solutions

Genvor Inc

March 4, 2026
Genvor’s AGM182 Antifungal Peptide Technology Validated in Peer-Reviewed Publication in PhytoFrontiers™

Genvor Inc

February 11, 2026
Genvor Appoints Dr. George Stavrides as Executive Vice President, Business Development & Commercialization

Genvor Inc

January 28, 2026